Lifestyle
GLP-1 treatment extends the lifespan of older, healthy mice
Abstract editorial illustration for: GLP-1 treatment extends the lifespan of older, healthy mice
AI Generated
Advertisement
A UC Berkeley-led study finds GLP-1 receptor agonists, drugs used for metabolic disorders, increased lifespan in older healthy mice. The results hint these treatments may act on fundamental aging biology, not just metabolic disease. Readers interested in aging therapies, drug repurposing, and potential human impacts will want the study details.
Originally published on UC Berkeley News by Strategic Communications on Sep 2, 2026. Republished with permission.
Related coverage
Politics
Bill regulating utility companies awaits Newsom
Politics
Californians to pay billions of dollars more in taxes
Politics
Strict clean air laws to stay in place, for now, in California
Lifestyle
Watch: UC Berkeley professor calls for a halt to AI weapons
Space Weather
Decagon wave emerges near Saturn’s south pole
Community
Charting a unique path from the ‘Salad Bowl of America’ to UC Berkeley
Lifestyle
UC Berkeley maintains its spot as the world’s top producer of startups and founders
Politics